Crescent Capital Bdc Inc Financials
Financial Health Signals
Crescent Capital Bdc Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
For every $1 of reported earnings, Crescent Capital Bdc Inc generates $0.80 in operating cash flow ($58.9M OCF vs $73.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Crescent Capital Bdc Inc earns $-1.7 in operating income for every $1 of interest expense (-$106.8M vs $62.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Crescent Capital Bdc Inc (CCAP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Crescent Capital Bdc Inc reported $73.6M in net income in fiscal year 2024. This represents a decrease of 12.2% from the prior year.
Crescent Capital Bdc Inc earned $2.40 per diluted share (EPS) in fiscal year 2024. This represents an increase of 4.3% from the prior year.
Crescent Capital Bdc Inc held $10.1M in cash against $875.8M in long-term debt as of fiscal year 2024.
Crescent Capital Bdc Inc had 37M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.
Crescent Capital Bdc Inc's ROE was 9.9% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 1.3 percentage points from the prior year.
CCAP Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$24.1M+6.1% | -$25.7M-2.8% | -$25.0M+8.9% | -$27.4M-2.3% | -$26.8M-0.5% | -$26.7M | N/A | -$26.1M |
| Interest Expense | $13.9M-8.4% | $15.2M+3.5% | $14.6M-9.1% | $16.1M+1.1% | $15.9M+2.1% | $15.6M | N/A | $15.4M |
| Income Tax | $0 | $0-100.0% | $6K-96.1% | $155K | $0 | N/A | N/A | N/A |
| Net Income | $7.1M-52.7% | $15.0M+284.6% | $3.9M-74.4% | $15.3M-25.1% | $20.4M-27.2% | $28.0M | N/A | $22.6M |
| EPS (Diluted) | $0.460.0% | $0.46+2.2% | $0.45-29.7% | $0.64+8.5% | $0.59-6.3% | $0.63 | N/A | $0.59 |
CCAP Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.6B-1.6% | $1.7B-0.7% | $1.7B+0.6% | $1.7B-1.0% | $1.7B+3.2% | $1.6B-0.4% | $1.6B+0.2% | $1.6B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $5.8M-40.6% | $9.7M-19.1% | $12.0M+18.8% | $10.1M-8.1% | $11.0M+63.4% | $6.7M-13.3% | $7.8M+29.7% | $6.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $913.6M-1.7% | $929.7M-1.0% | $939.4M+2.6% | $915.6M-0.5% | $920.0M+5.9% | $868.7M-1.8% | $884.8M-1.1% | $894.2M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $875.3M-1.4% | $887.3M-1.7% | $903.0M+3.1% | $875.8M-0.5% | $879.9M+5.8% | $831.4M-1.6% | $844.8M-1.4% | $856.7M |
| Total Equity | $714.1M-1.5% | $724.7M-0.3% | $727.1M-1.8% | $740.6M-1.6% | $752.4M+0.1% | $751.7M+1.2% | $742.6M+1.7% | $730.3M |
| Retained Earnings | -$244.7M-4.4% | -$234.4M-1.0% | -$232.0M-6.2% | -$218.5M-2.3% | -$213.5M+0.3% | -$214.2M+4.1% | -$223.3M-284.6% | -$58.1M |
CCAP Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $30.8M-15.6% | $36.4M+340.9% | -$15.1M-423.6% | -$2.9M+88.3% | -$24.6M-162.4% | $39.5M+14.1% | $34.6M+62.1% | $21.4M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$29.1M+29.0% | -$40.9M-745.2% | $6.3M+27.7% | $5.0M-82.7% | $28.8M+190.1% | -$31.9M+3.2% | -$33.0M-64.7% | -$20.0M |
| Dividends Paid | $17.4M-0.1% | $17.4M0.0% | $17.4M-4.1% | $18.2M-5.8% | $19.3M+2.0% | $18.9M+2.0% | $18.5M+2.0% | $18.2M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CCAP Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 1.0%-1.1pp | 2.1%+1.5pp | 0.5%-1.5pp | 2.0%-0.7pp | 2.7%-1.0pp | 3.7% | N/A | 3.1% |
| Return on Assets | 0.4%-0.5pp | 0.9%+0.7pp | 0.2%-0.7pp | 0.9%-0.3pp | 1.2%-0.5pp | 1.7% | N/A | 1.4% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 1.230.0 | 1.22-0.0 | 1.24+0.1 | 1.18+0.0 | 1.17+0.1 | 1.11-0.0 | 1.14-0.0 | 1.17 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Crescent Capital Bdc Inc profitable?
Yes, Crescent Capital Bdc Inc (CCAP) reported a net income of $73.6M in fiscal year 2024.
What is Crescent Capital Bdc Inc's earnings per share (EPS)?
Crescent Capital Bdc Inc (CCAP) reported diluted earnings per share of $2.40 for fiscal year 2024. This represents a 4.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Crescent Capital Bdc Inc have?
As of fiscal year 2024, Crescent Capital Bdc Inc (CCAP) had $10.1M in cash and equivalents against $875.8M in long-term debt.
What is Crescent Capital Bdc Inc's return on equity (ROE)?
Crescent Capital Bdc Inc (CCAP) has a return on equity of 9.9% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Crescent Capital Bdc Inc's operating cash flow?
Crescent Capital Bdc Inc (CCAP) generated $58.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Crescent Capital Bdc Inc's total assets?
Crescent Capital Bdc Inc (CCAP) had $1.7B in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Crescent Capital Bdc Inc have outstanding?
Crescent Capital Bdc Inc (CCAP) had 37M shares outstanding as of fiscal year 2024.
What is Crescent Capital Bdc Inc's debt-to-equity ratio?
Crescent Capital Bdc Inc (CCAP) had a debt-to-equity ratio of 1.18 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Crescent Capital Bdc Inc's return on assets (ROA)?
Crescent Capital Bdc Inc (CCAP) had a return on assets of 4.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Crescent Capital Bdc Inc's Piotroski F-Score?
Crescent Capital Bdc Inc (CCAP) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Crescent Capital Bdc Inc's earnings high quality?
Crescent Capital Bdc Inc (CCAP) has an earnings quality ratio of 0.80x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Crescent Capital Bdc Inc cover its interest payments?
Crescent Capital Bdc Inc (CCAP) has an interest coverage ratio of -1.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.